SBI Securities’s T-Rex 2X Inverse MSTR Daily Target ETF MSTZ Stock Holding History

SBI Securities’s Portfolio MSTZ Stock Details MSTZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$18.1K	Sell	1,163 -12,485	-91%	-$105K	﹤0.01%	1581
2026 Q1	$170K	Sell	13,648 -3,020	-18%	-$40.4K	﹤0.01%	678
2025 Q4	$286K	Sell	16,668 -9,269	-36%	-$94.2K	0.01%	519
2025 Q3	$136K	Buy	25,937 +23,191	+845%	+$104K	﹤0.01%	751
2025 Q2	$11.5K	Buy	2,746 +2,001	+269%	+$12.6K	﹤0.01%	1645
2025 Q1	$10.5K	Buy	745 +701	+1,593%	+$12.3K	﹤0.01%	1590
2024 Q4	$1.24K	Buy	+44	New	+$3.77K	﹤0.01%	2515

Other funds holding MSTZ

IMC Chicago Chicago, Illinois $419B AUM 72.04% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

GWM

Geneos Wealth Management Englewood, Colorado $4.9B AUM 23.65% 1-Year Est. Return

SBI Securities's MSTZ Position: Q2 2026 in Review

SBI Securities reduced its T-Rex 2X Inverse MSTR Daily Target ETF (MSTZ) stake by 91% in Q2 2026, selling an estimated $105K and leaving 1,163 shares worth $18.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1581.

SBI Securities first reported a position in MSTZ in Q4 2024 and has held it in 7 quarters since. The position peaked at $286K in Q4 2025. 4 funds tracked by Wall St. Rank hold MSTZ as of Q2 2026.

SBI Securities held 1,163 shares of T-Rex 2X Inverse MSTR Daily Target ETF worth $18.1K as of Q2 2026.
SBI Securities sold 12,485 T-Rex 2X Inverse MSTR Daily Target ETF shares in Q2 2026, an estimated $105K.
T-Rex 2X Inverse MSTR Daily Target ETF made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #1581 holding.
SBI Securities first reported a position in T-Rex 2X Inverse MSTR Daily Target ETF in Q4 2024 and has held it in 7 quarters since.
SBI Securities's T-Rex 2X Inverse MSTR Daily Target ETF position peaked at $286K in Q4 2025.
4 funds tracked by Wall St. Rank held T-Rex 2X Inverse MSTR Daily Target ETF as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.